Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Doses of RG7667 in Healthy Adult Volunteers

NCT01496755 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01496755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01496755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Doses of RG7667 in Healthy Adult Volunteers
Lead sponsor
Genentech, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
January 31, 2013
Enrollment
170 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer